ICG-001 is a research compound that functions as a selective inhibitor of the CREB-binding protein (CBP) and p300 interaction with β-catenin. It is primarily used in laboratory studies to investigate the role of CBP/p300 in cellular signaling and gene transcription.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing ICG-001?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
5-Methoxyuridine 5'-triphosphate
research compound
(S)-2-(Methylamino)-3-phenylpropan-1-ol
research compound
Compound 48/80 (trihydrochloride)
research compound
5-Formylpyridine-3-boronic acid pinacol ester
research compound
(6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-8-(naphthalen-1-ylmethyl)-4,7-dioxo-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide
HQWTUOLCGKIECB-XZWHSSHBSA-N
C1CN([C@H]2CN(C(=O)[C@@H](N2C1=O)CC3=CC=C(C=C3)O)CC4=CC=CC5=CC=CC=C54)C(=O)NCC6=CC=CC=C6
Sourcing ICG-001?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.